Market at record high: Sensex tops 42,000 for first time; Nifty nears 12,400
Barring auto and metal, all sectoral indices on NSE were trading with gains.
'BUY' or 'SELL' ideas from experts for Thursday, 16 January, 2020
Aurobindo Pharma is a 'Buy' call with a target price of Rs 535 and a stop loss of Rs 472.
Share market update: Pharma shares up; Aurobindo Pharma gains 2%
The Nifty Pharma index was trading 0.91 per cent up at 8068.7 .
Stock market update: Pharma stocks zoom; Sun Pharma gains over 1%
The Nifty Pharma index was trading 1.1 per cent up at 8,121.2.
Share market update: GTN Industries, Adani Green among top losers on BSE
In the Nifty pack, 15 stocks were in the green, while 35 stocks were in the red.
'BUY' or 'SELL' ideas from experts for Wednesday, 15 January, 2020
Asian Paints is a 'Buy' call with a target price of Rs 1860 and a stop loss of Rs 1797.
ICICI Pru has just offloaded Airtel, Voda; picked bank, power, pharma stocks
Overall, it increased stakes in over 350 companies from across sectors in December.
Sun Pharma eyes China, Japan markets
Shanghai now plans to steer the company into the specialty business (novel, innovative drugs), and towards expanding markets like China and Japan for growth, both through acquisitions and partnerships.
USFDA classifies inspection of Lupin's Tarapur facility as 'Official Action Indicated'
According to FDA's definitions, Official Action Indicated means "objectionable conditions were found and regulatory administrative sanctions by FDA are indicated" during inspections. The company, however, said that it does not believe this inspection classification will have an impact on disruption of supplies or the existing revenues from operations of this facility.
Stocks in news: Alembic Pharma, SBI and Vedanta
Here are the top stocks that are likely to be in focus in today's trading.Stocks in news: Alembic Pharma, SBI and Vedanta
Citi turns positive on pharma; Aurobindo, Biocon top bets
Citi has upgraded Dr Reddy Laboratories to ‘buy’ from ‘sell’ earlier. It has a target of Rs 3,380 on the stock.
Government mulls tax break for Indian pharma companies
The government had introduced a weighted tax deduction of 200% on expenditure on R&D in the 2010 budget, in order to boost innovation in the country. However, the government slashed the benefit to 150% from 2017 onwards and 100% from 2020.
Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall
"We understand from Mylan NV's press release dated January 8, 2020, that Mylan Pharmaceuticals has initiated a voluntary recall of three lots of Nizatidine Capsules, USP (150 mg and 300 mg strengths) due to detected trace amounts of impurity...," Solara Active Pharma Sciences in a filing to BSE.
Alembic Pharma jumps 3% as JV firm completes USFDA inspection
Alembic Pharma manufactures and markets generic pharmaceutical products across the globe.
Stocks in the news: Gati, Bharti Airtel, Alembic Pharma, Aster DM and DHFL
GMR Infra has raised Rs 2,000 crore debt through nonconvertible debentures from Tata Sons.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service